EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis

NYSE:EVH • US30050B1017

2.79 USD
+0.15 (+5.68%)
At close: Feb 13, 2026
2.79 USD
0 (0%)
After Hours: 2/13/2026, 8:05:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

EVH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of EVH have multiple concerns. EVH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year EVH has reported negative net income.
  • EVH had a negative operating cash flow in the past year.
  • EVH had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: EVH reported negative operating cash flow in multiple years.
EVH Yearly Net Income VS EBIT VS OCF VS FCFEVH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • EVH has a Return On Assets of -7.37%. This is in the better half of the industry: EVH outperforms 62.86% of its industry peers.
  • The Return On Equity of EVH (-21.48%) is better than 62.86% of its industry peers.
  • EVH has a Return On Invested Capital (0.68%) which is in line with its industry peers.
Industry RankSector Rank
ROA -7.37%
ROE -21.48%
ROIC 0.68%
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
EVH Yearly ROA, ROE, ROICEVH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

  • Looking at the Operating Margin, with a value of 0.86%, EVH is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
  • The Gross Margin of EVH (18.42%) is worse than 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of EVH has declined.
Industry RankSector Rank
OM 0.86%
PM (TTM) N/A
GM 18.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
EVH Yearly Profit, Operating, Gross MarginsEVH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EVH is destroying value.
  • Compared to 1 year ago, EVH has more shares outstanding
  • The number of shares outstanding for EVH has been increased compared to 5 years ago.
  • Compared to 1 year ago, EVH has a worse debt to assets ratio.
EVH Yearly Shares OutstandingEVH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EVH Yearly Total Debt VS Total AssetsEVH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.54, we must say that EVH is in the distress zone and has some risk of bankruptcy.
  • EVH has a Altman-Z score (0.54) which is in line with its industry peers.
  • EVH has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of EVH (1.26) is worse than 88.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACC0.1
WACC6.87%
EVH Yearly LT Debt VS Equity VS FCFEVH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that EVH should not have too much problems paying its short term obligations.
  • The Current ratio of EVH (1.33) is worse than 65.71% of its industry peers.
  • EVH has a Quick Ratio of 1.33. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of EVH (1.33) is worse than 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
EVH Yearly Current Assets VS Current LiabilitesEVH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.10%.
  • The Earnings Per Share has been growing by 220.75% on average over the past years. This is a very strong growth
  • The Revenue for EVH has decreased by -16.65% in the past year. This is quite bad
  • The Revenue has been growing by 30.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%

3.2 Future

  • Based on estimates for the next years, EVH will show a small growth in Earnings Per Share. The EPS will grow by 8.00% on average per year.
  • EVH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.65% yearly.
EPS Next Y-88.92%
EPS Next 2Y-27.05%
EPS Next 3Y-7.07%
EPS Next 5Y8%
Revenue Next Year-26.73%
Revenue Next 2Y-3.58%
Revenue Next 3Y1.67%
Revenue Next 5Y6.65%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EVH Yearly Revenue VS EstimatesEVH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
EVH Yearly EPS VS EstimatesEVH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EVH. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 7.94 indicates a rather cheap valuation of EVH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EVH indicates a rather cheap valuation: EVH is cheaper than 91.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, EVH is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.94
EVH Price Earnings VS Forward Price EarningsEVH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EVH is valued a bit cheaper than 77.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.62
EVH Per share dataEVH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as EVH's earnings are expected to decrease with -7.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.05%
EPS Next 3Y-7.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • EVH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EVOLENT HEALTH INC - A

NYSE:EVH (2/13/2026, 8:05:44 PM)

After market: 2.79 0 (0%)

2.79

+0.15 (+5.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-24
Inst Owners124.12%
Inst Owner Change-0.66%
Ins Owners1.56%
Ins Owner Change3.93%
Market Cap311.36M
Revenue(TTM)2.05B
Net Income(TTM)-180.88M
Analysts84
Price Target9.33 (234.41%)
Short Float %17.44%
Short Ratio5.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.54%
Min EPS beat(2)-226.45%
Max EPS beat(2)-52.63%
EPS beat(4)0
Avg EPS beat(4)-162.45%
Min EPS beat(4)-332.96%
Max EPS beat(4)-37.77%
EPS beat(8)3
Avg EPS beat(8)-78.52%
EPS beat(12)6
Avg EPS beat(12)-25.77%
EPS beat(16)10
Avg EPS beat(16)442.42%
Revenue beat(2)1
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)1.03%
PT rev (1m)-10.18%
PT rev (3m)-41.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-52.15%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-70.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.94
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB N/A
EV/EBITDA 10.62
EPS(TTM)-0.01
EYN/A
EPS(NY)0.35
Fwd EY12.59%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS18.41
BVpS7.55
TBVpS-7.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.37%
ROE -21.48%
ROCE 0.87%
ROIC 0.68%
ROICexc 0.73%
ROICexgc 6.52%
OM 0.86%
PM (TTM) N/A
GM 18.42%
FCFM N/A
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score4
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Debt/EBITDA 9.01
Cap/Depr 32.44%
Cap/Sales 1.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 0.54
F-Score4
WACC6.87%
ROIC/WACC0.1
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-88.92%
EPS Next 2Y-27.05%
EPS Next 3Y-7.07%
EPS Next 5Y8%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
Revenue Next Year-26.73%
Revenue Next 2Y-3.58%
Revenue Next 3Y1.67%
Revenue Next 5Y6.65%
EBIT growth 1Y218.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year297.48%
EBIT Next 3Y70.85%
EBIT Next 5Y48.16%
FCF growth 1Y-223.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.71%
OCF growth 3Y-21.47%
OCF growth 5YN/A

EVOLENT HEALTH INC - A / EVH FAQ

What is the fundamental rating for EVH stock?

ChartMill assigns a fundamental rating of 2 / 10 to EVH.


Can you provide the valuation status for EVOLENT HEALTH INC - A?

ChartMill assigns a valuation rating of 3 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Overvalued.


Can you provide the profitability details for EVOLENT HEALTH INC - A?

EVOLENT HEALTH INC - A (EVH) has a profitability rating of 2 / 10.


Can you provide the financial health for EVH stock?

The financial health rating of EVOLENT HEALTH INC - A (EVH) is 1 / 10.